HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Larissa Nekhlyudov Selected Research

Anthracyclines

9/2022Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy.
5/2014Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer.
9/2012Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Larissa Nekhlyudov Research Topics

Disease

36Neoplasms (Cancer)
04/2024 - 04/2006
18Breast Neoplasms (Breast Cancer)
06/2020 - 05/2002
10Noninfiltrating Intraductal Carcinoma (DCIS)
01/2018 - 01/2009
2Melanoma (Melanoma, Malignant)
05/2024 - 12/2018
2Peripheral Nervous System Diseases (PNS Diseases)
12/2023 - 03/2014
2Cardiomyopathies (Cardiomyopathy)
09/2022 - 09/2012
2COVID-19
03/2022 - 01/2021
2Lung Neoplasms (Lung Cancer)
01/2020 - 12/2018
2Necrosis
01/2018 - 12/2009
2Unilateral Breast Neoplasms
03/2017 - 01/2005
2Ovarian Neoplasms (Ovarian Cancer)
01/2014 - 10/2009
1Hypothyroidism
12/2022
1Inflammation (Inflammations)
12/2022
1Hemorrhage
10/2022
1Stroke (Strokes)
10/2022
1Left Ventricular Dysfunction
09/2022
1Fatigue
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Adenocarcinoma
01/2020
1Obesity
09/2018
1Osteosarcoma (Osteogenic Sarcoma)
09/2018
1Cardiotoxicity
05/2014
1Premature Menopause
03/2014
1Colonic Neoplasms (Colon Cancer)
03/2014
1Heart Failure
09/2012

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2020
3AnthracyclinesIBA
09/2022 - 09/2012
3Trastuzumab (Herceptin)FDA Link
05/2014 - 09/2012
24-hydroxybenzylcyanideIBA
06/2020 - 10/2019
2Estrogen ReceptorsIBA
01/2018 - 12/2009
2human ERBB2 proteinIBA
11/2012 - 12/2009
1TabletsIBA
05/2024
1Moclobemide (Arima)IBA
05/2023
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022
1Aligeron (AS 2)IBA
10/2018
1Cisplatin (Platino)FDA LinkGeneric
09/2018
1Asparaginase (Elspar)FDA Link
09/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2014
1Paclitaxel (Taxol)FDA LinkGeneric
03/2014
1Dihydrotachysterol (AT 10)IBA
05/2012
1Progesterone Receptors (Progesterone Receptor)IBA
12/2009
1Hormones (Hormone)IBA
06/2009
1TamoxifenFDA LinkGeneric
01/2009

Therapy/Procedure

17Therapeutics
01/2024 - 01/2009
10Aftercare (After-Treatment)
12/2022 - 07/2009
8Drug Therapy (Chemotherapy)
12/2023 - 10/2009
7Prophylactic Mastectomy
03/2017 - 01/2005
6Segmental Mastectomy (Lumpectomy)
01/2018 - 01/2009
5Continuity of Patient Care
11/2023 - 09/2014
3Radiotherapy
11/2014 - 05/2010
2Palliative Care (Palliative Therapy)
04/2024 - 04/2024
2Terminal Care (Care, Terminal)
01/2023 - 10/2014
1Dental Care
04/2024
1Long-Term Care
01/2024
1Immunotherapy
12/2022
1Cranial Irradiation
10/2022
1Treatment Delay
10/2018
1Surgical Amputation (Amputations)
09/2018
1Limb Salvage
09/2018
1Transjugular Intrahepatic Portasystemic Shunt
04/2015
1Shared Medical Appointments
01/2015
1Adjuvant Radiotherapy
01/2009
1Estrogen Replacement Therapy
05/2002